Axios' bio-based trackable pallet and software technology achieves FDA compliance
Axios Mobile Assets Corporation today announced it has achieved FDA compliance for its proprietary bio-based trackable pallet and software technology. The solutions meet FDA standards for CFR 21 part 11 compliance based on the pallet's material composition, in accordance to the U.S. Federal Code of Regulation.

CytRx s INNO-206 Receives FDA Approval for Orphan Drug Designation for Pancreatic Cancer
LOS ANGELES--(BUSINESSWIRE)-- CytRx Corporation , a biopharmaceutical company specializing in oncology, today announced that its tumor-targeting pro-drug candidate INNO-206 has been approved ...